FloridaMarijuana.net

JUNE 13, 2018

For centuries, humans have relied on the cannabis plant for its therapeutic properties. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. Cannabis has given cancer patients relief , improved their mood and anxiety, and relieved insomnia.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

JUNE 21, 2021

In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JUNE 7, 2022

Cannabidiol or CBD is a compound derived from the Cannabis sativa plant, more prominently known as cannabis or hemp. On the contrary, researchers are leaning more towards CBD as a beneficial chemical with therapeutic effects on various physical and mental health problems, from anxiety to chronic pain.

Chronic Pain 52

Chronic Pain CBD Digestion Edibles 52

Canna Care Docs

DECEMBER 11, 2018

For many who were young in the 1960s and 70s, cannabis was something seen at parties, possibly experimented with, but for the most part set aside. But what explains this turnaround, and what do seniors need to be aware of when it comes to medical cannabis? Here, too, cannabis has been shown to have a distinct effect.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. Medicinal cannabis as a last resort.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

SEPTEMBER 6, 2021

DUBLIN–(BUSINESS WIRE)–The “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The global medical cannabis market exhibited strong growth during 2015-2020. Aurora Cannabis Inc.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. As the United States navigates through a complex web of legal, social, and medical considerations, public opinion on medical cannabis has evolved significantly over the years.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Canna Care Docs

DECEMBER 16, 2020

Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). The range of products available to recreational and medical cannabis users contain varying levels of THC and CBD. Chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

MARCH 17, 2022

CBD oil is a naturally occurring substance found in the cannabis plant that has gained popularity for providing many health benefits. CBD, short for cannabidiol, has become incredibly popular because of its potential to mitigate chronic pain, nausea, and even PTSD. The CBD oil form is an edible, topical cream. Conclusion.

Oil 52

Oil CBD Chronic Pain Extraction 52

The Cannigma

SEPTEMBER 21, 2021

In the world of cannabis, not everyone can be Snoop, Seth Rogen, or Willie Nelson. There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. Patrick Stewart uses topicals and edibles for his arthritis (Shutterstock). 1) Patrick Stewart. 1) Patrick Stewart.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

CannaTech

SEPTEMBER 16, 2018

Changing Cannabis Conversations Worldwide. Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. While Canada’s medicinal cannabis framework has gone through many iterations, Canada has led the way in showing to the world how to think about cannabis.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

The Herb Collective

JUNE 3, 2018

As Cannabis sales soar around the world, Cannabidiol oil (CBD) is garnering more excitement than the market can stand. Recent clinical studies support its efficacy in burning fat cells, delaying the onset of chronic disease indicators, treating mental health conditions, and killing bacteria.

Oil 56

Oil CBD Blood Pressure Chronic Pain 56

The Joint Blog

APRIL 22, 2022

Cannabidiol, also popularly known as CBD, is a chemical compound derived from cannabis Sativa plants. There are multiple ways to ingest this oil; one can apply it topically, consume it through smoke inhalation or in the form of edible. It can help opioid-addicted patients dealing with anxiety, pain, and insomnia.

Oil 26

Oil CBD Topical Clinical Trials 26

The Cannigma

JUNE 24, 2021

Hemp and cannabis-derived medications may not be quite as mainstream as apple pie or multivitamins, but the days in which it was an almost completely illegal plant with little if any recognized medical benefits seem like a distant memory. That doesn’t mean that CBD or other cannabis products should be seen as a cure all on their own.

CBD 75

CBD Microdosing Edibles Sleep 75

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 24, 2019

Marketwatch report… Shares of cannabis company Curaleaf Holdings Inc. On your product webpage for CBD Tincture (Relieve): • “[S]oothing tincture for chronic pain.”. Chronic or arthritic pain.”. Chronic pain. Chronic pain from fibromyalgia, slipped spinal discs.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

JUNE 11, 2019

This article will examine how courts have responded to claims for cannabis, as an element of future care costs, in personal injury cases. These claims have occurred against a background of significant change with regards to the acceptance of cannabis, both medically and recreationally. Awards for Cannabis as a Future Care Cost.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

The Cannigma

DECEMBER 12, 2022

Just as THCA in cannabis flower needs to be decarboxylated into the active compound THC, psilocybin is not active until it undergoes a chemical reaction. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. However, like cannabis , the root of this shrub produces many bioactive molecules.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Virpax is initially seeking FDA approval of its three patented drug delivery platforms.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Project CBD

MAY 3, 2023

This transcript is adapted from CannMed’s weekly podcast , hosted by Ben Amirault, who recently interviewed Bonni Goldstein, MD, one of the country’s most respected and experienced medical cannabis physicians. Dr. Goldstein has treated thousands of patients with medical cannabis. CBG is not intoxicating or impairing.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

The Cannigma

JANUARY 13, 2023

Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. Cannabis users have been reporting anecdotal relief for years, but it’s only recently that research has begun to dig into the complexities of migraines and how – or why – cannabis may be able to bring relief.

Terpenes 132

Terpenes Strains THC Treatment 132

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. THC, the primary psychoactive component of cannabis. The cannabis oil is made out of extract from the Avidekel strain and olive oil.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

SEPTEMBER 9, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global legal cannabis market size is expected to reach USD 91.5 have gone a step further and legalized the recreational use of cannabis. over the forecast period.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. In October 2021, Virpax announced that a $1.87

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

OCTOBER 6, 2021

With the additional funding recently secured by Virpax and the strengthening of our balance sheet, we are continuing to advance our product candidates and to move them through preclinical studies and into human clinical trials,” said Anthony Mack, Chairman and Chief Executive Officer of Virpax Pharmaceuticals.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. 9-THC, the primary psychoactive component of cannabis. Cannabis oil: TO Pharmaceuticals. One World Cannabis. Dronabinol.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 108

Programs Research and Development Education Treatment 108

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. On September 9, 2021, Jeffrey A.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

APRIL 8, 2021

Listen & Subscribe: As both a regulated medicine and something people use for wellness and even recreation, the information gaps that exist for cannabis users are unprecedented. Any other medication and you’re lawfully entitled to speak to a pharmacist,” explains Dr. Codi Peterson, a clinical pharmacist and medical cannabis professional.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

DECEMBER 28, 2021

Epoladerm™ Epoladerm is a diclofenac topical spray film product candidate that is being developed for pain associated with osteoarthritis of the knee. Once completed, we plan to perform seven preclinical animal studies as part of required FDA IND enabling trials. to conduct this study in Canada.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

OCTOBER 1, 2021

Virpax is developing branded, non-addictive pain management and neurological product candidates using its proprietary technologies to optimize and target drug delivery. Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 20, 2021

Virpax is developing branded, non-addictive pain management product candidates using its proprietary technologies to optimize and target drug delivery. Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 40

Programs Research and Development Education Treatment 40